Kidney transplant study probes immune cell changes after induction therapy
NCT ID NCT02894606
First seen Jun 09, 2026 · Last updated Jun 14, 2026 · Updated 1 time
Summary
This study examined how two different induction drugs (thymoglobulin and basiliximab) affect B cells—a type of immune cell—in 49 kidney transplant recipients. Researchers compared B cell profiles shortly after transplant to better understand immune responses. The goal was to gather knowledge, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Brest
Brest, 29200, France
-
Tours University Hospital
Tours, 37000, France
Conditions
Explore the condition pages connected to this study.